↓ Skip to main content

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Overview of attention for article published in JAMA Oncology, September 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news
1 news outlet
twitter
48 X users
patent
2 patents
facebook
1 Facebook page
googleplus
2 Google+ users
guideline
2 clinical guideline sources
podcasts
1 podcast

Readers on

mendeley
136 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality
Published in
JAMA Oncology, September 2017
DOI 10.1001/jamaoncol.2017.2714
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 136 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 14 10%
Student > Bachelor 13 10%
Researcher 13 10%
Student > Master 9 7%
Student > Postgraduate 9 7%
Other 21 15%
Unknown 57 42%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 49 36%
Engineering 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Biochemistry, Genetics and Molecular Biology 2 1%
Nursing and Health Professions 2 1%
Other 11 8%
Unknown 64 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2023.
All research outputs
#948,584
of 34,184,245 outputs
Outputs from JAMA Oncology
#1,340
of 3,943 outputs
Outputs of similar age
#14,644
of 353,703 outputs
Outputs of similar age from JAMA Oncology
#40
of 103 outputs
Altmetric has tracked 34,184,245 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,943 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 81.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,703 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.